Jeffrey W. Albers's Net Worth
$65.6 Million
Estimate Recalculated Nov 11, 2024 08:40AM EST
Who is Jeffrey W. Albers?
Jeffrey W. Albers has an estimated net worth of $65.6 Million. This is based on reported shares across multiple companies, which include Blueprint Medicines Corp, Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., and Spyre Therapeutics, Inc..
SEC CIK
Jeffrey W. Albers's CIK is 0001638474
Past Insider Trading and Trends
2022 was Jeffrey W. Albers's most active year for acquiring shares with 17 total transactions. Jeffrey W. Albers's most active month to acquire stocks was the month of February. 2022 was Jeffrey W. Albers's most active year for disposing of shares, totalling 31 transactions. Jeffrey W. Albers's most active month to dispose stocks was the month of February. 2021 saw Jeffrey W. Albers paying a total of $1,098,120.00 for 269,251 shares, this is the most they've acquired in one year. In 2021 Jeffrey W. Albers cashed out on 214,986 shares for a total of $10,340,373.05, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Blueprint Medicines Corp (BPMC) Snapshot price: $86.43
CEO AND PRESIDENT
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.80% | -9.70K |
$60.81 | -$1,325,390.56 | 157.56K |
Scheduled
|
Sep 9
| ||
Form 4
| +1.36% | 2.24K |
—
|
—
| 167.26K |
Jun 12
| |||
Form 4
| -6.27% | -11.03K |
$90.69 | -$1,000,582.77 | 165.02K |
Mar 7
| |||
Form 4
|
—
|
0
|
$47.20 | -$2,009,977.99 | 176.05K |
Scheduled
|
Mar 20
| ||
Form 4
|
—
|
0
|
$44.52 | -$1,869,650.00 | 176.05K |
Scheduled
|
Jan 25
| ||
Form 4
|
—
|
0
|
$57.56 | -$215,100.00 | 176.05K |
Scheduled
|
Dec 11
| ||
Form 4
|
—
|
0
|
$53.30 | -$172,500.00 | 176.05K |
Nov 30
| |||
Form 4
|
—
|
0
|
$34.69 | -$984,640.16 | 176.05K |
Scheduled
|
Nov 24
| ||
Form 4
|
—
|
0
|
$48.13 | -$241,479.62 | 176.05K |
Scheduled
|
Nov 1 - Nov 3
| ||
Form 4
|
—
|
0
|
$25.82 | -$1,197,279.52 | 176.05K |
Sep 27 - Sep 28
| |||
Form 4
|
—
|
0
|
$25.84 | -$1,198,400.00 | 176.05K |
Aug 24 - Aug 25
| |||
Form 4
| +1.50% | 2.6K |
—
|
—
| 176.05K |
Jun 21
| |||
Form 4
| -5.34% | -9.79K |
$45.67 | -$447,273.41 | 173.45K |
Mar 6
| |||
Form 4
|
—
|
0
|
$29.27 | -$833,000.00 | 183.24K |
Scheduled
|
Dec 5
| ||
Form 4
|
—
|
0
|
$42.73 | -$554,433.96 | 183.24K |
Scheduled
|
Aug 19 - Aug 22
| ||
Form 4
|
—
|
0
|
$38.42 | -$1,199,453.40 | 183.24K |
Scheduled
|
Aug 16
| ||
Form 4
|
—
|
0
|
$38.46 | -$632,311.90 | 183.24K |
Scheduled
|
Aug 8
| ||
Form 4
|
—
|
0
|
$32.17 | -$949,014.64 | 183.24K |
Scheduled
|
May 16
| ||
Form 4
|
—
|
0
|
$42.56 | -$275,500.00 | 183.24K |
Scheduled
|
Apr 6
| ||
Form 4
| -6.48% | -12.71K |
$33.99 | -$1,692,061.78 | 183.24K |
Scheduled
|
Mar 3 - Mar 7
| ||
Form 4
| +3.98% | 7.5K |
—
|
—
| 195.95K |
Mar 1
| |||
Form 4
|
—
|
0
|
$63.12 | -$3,083,348.86 | 188.45K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$65.08 | -$500,750.00 | 188.45K |
Scheduled
|
Nov 1
| ||
Form 4
| +9.28% | 16K |
$1.87 | $29,920.00 | 188.45K |
Aug 26
| |||
Form 4
|
—
|
0
|
$51.88 | -$2,040,402.00 | 172.45K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$51.88 | -$2,040,665.75 | 172.45K |
Scheduled
|
May 12
| ||
Form 4
| -4.95% | -8.99K |
$49.04 | -$1,607,006.44 | 172.45K |
Scheduled
|
Mar 4
| ||
Form 4
| +28.28% | 40K |
—
|
—
| 181.43K |
Mar 1
| |||
Form 4
|
—
|
0
|
$63.99 | -$551,900.00 | 141.43K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$53.76 | -$1,798,294.52 | 141.43K |
Scheduled
|
Nov 16
| ||
Form 4
|
—
|
0
|
$53.99 | -$451,850.00 | 141.43K |
Scheduled
|
Oct 7
| ||
Form 4
|
—
|
0
|
$41.91 | -$1,324,438.22 | 141.43K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$36.74 | -$1,117,427.24 | 141.43K |
Scheduled
|
May 12
| ||
Form 4
| +16.47% | 20K |
$28.71 | -$829,076.86 | 141.43K |
Scheduled
|
Mar 23
| ||
Form 4
| -1.84% | -2.28K |
$51.97 | -$118,335.69 | 121.43K |
Mar 9
| |||
Form 4
| +57.17% | 45K |
—
|
—
| 123.71K |
Mar 1
| |||
Form 4
|
—
|
0
|
$38.74 | -$1,447,024.80 | 48.96K |
Scheduled
|
Nov 8 - Nov 18
| ||
Form 4
| +69.06% | 20K |
$1.87 | $37,400.00 | 48.96K |
Oct 30
| |||
Form 4
|
—
|
0
|
$41.80 | -$1,597,261.14 | 28.96K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$50.47 | -$485,950.00 | 28.96K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$43.31 | -$1,657,506.01 | 28.96K |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
$44.13 | -$1,690,483.73 | 28.96K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
∞
| 28.96K |
$1.87 | $54,157.07 | 28.96K |
Nov 19
| |||
Form 4
|
—
|
0
|
$32.68 | -$1,232,309.00 |
0
|
Scheduled
|
Nov 5
| ||
Form 4
|
—
|
0
|
$36.23 | -$1,374,496.46 |
0
|
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
$40.39 | -$1,540,691.20 |
0
|
Scheduled
|
May 7
| ||
Form 4
|
—
|
0
|
$47.22 | -$1,814,062.92 |
0
|
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -100.00% | -5.49K |
$36.09 | -$2,063,409.77 |
0
|
Scheduled
|
Nov 6
| ||
Form 4
| -84.54% | -30.00K |
$49.62 | -$1,488,636.88 | 5.49K |
Scheduled
|
Aug 7 - Aug 8
| ||
Form 4
| -36.05% | -20.00K |
$50.47 | -$1,009,393.86 | 35.49K |
Scheduled
|
Jun 28
| ||
Form 4
| -26.49% | -20.00K |
$40.03 | -$800,515.80 | 55.49K |
Scheduled
|
Mar 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -18.38% | -17.00K |
$22.86 | -$388,663.04 | 75.49K |
Scheduled
|
Aug 8
| ||
Form 4
| -15.53% | -17.00K |
$20.03 | -$340,510.00 | 92.49K |
Scheduled
|
Jun 3
| ||
Form 4
| -13.44% | -17.00K |
$20.42 | -$347,140.00 | 109.49K |
Scheduled
|
Apr 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
| -5.24% | -7.00K |
$21.87 | -$153,090.00 | 126.49K |
Scheduled
|
Nov 10
| ||
Form 4
| -6.97% | -10.00K |
$21.02 | -$210,200.00 | 133.49K |
Scheduled
|
Nov 2
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$29.72 | -$193,808.50 |
0
|
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
$24.70 | -$143,557.67 |
0
|
Feb 20 - Feb 21
| |||
Form 4
|
—
|
0
|
$20.20 | -$197,070.00 |
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 4.15K |
—
|
—
| 4.15K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Spyre Therapeutics, Inc. (SYRE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.67% | -6.70K |
$36.76 | -$246,312.77 | 27.36K |
Scheduled
|
Nov 6
| ||
Form 4
| -0.87% | -300.00 |
$36.43 | -$10,929.00 | 34.06K |
Scheduled
|
Oct 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4/A
|
∞
| 34.36K |
—
|
—
| 34.36K |
Nov 22 - Nov 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||